{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:02:07Z","timestamp":1762866127027},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jcv.2013.01.009","type":"journal-article","created":{"date-parts":[[2013,1,31]],"date-time":"2013-01-31T10:16:34Z","timestamp":1359627394000},"page":"5-12","source":"Crossref","is-referenced-by-count":22,"title":["Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe"],"prefix":"10.1016","volume":"57","author":[{"given":"Francisco","family":"Pozo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Lina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena Rebelo de","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Enouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasios","family":"Kossyvakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eeva","family":"Broberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rod","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angie","family":"Lackenby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2013.01.009_bib0005","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(11)70318-8","article-title":"Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives","volume":"12","author":"Hurt","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jcv.2013.01.009_bib0010","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.2807\/esm.12.04.00698-en","article-title":"Influenza antiviral susceptibility monitoring activities in relation to national antiviral stockpiles in Europe during the winter 2006\/2007 season","volume":"12","author":"Meijer","year":"2007","journal-title":"Euro Surveill"},{"issue":"1 Pt B","key":"10.1016\/j.jcv.2013.01.009_bib0015","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jcv.2013.01.009_bib0020","series-title":"Antimicrobial Drug Resistance, Volume 1, Mechanisms of Drug Resistance","first-page":"421","article-title":"Influenza M2 Ion-channel and neuraminidase inhibitors","author":"Tisdale","year":"2009"},{"key":"10.1016\/j.jcv.2013.01.009_bib0025","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1086\/648424","article-title":"Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007\u20132008 and 2008\u20132009 influenza seasons","volume":"49","author":"Kawai","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2013.01.009_bib0030","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2014Geneva, November 2011 and June 2012","volume":"39","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.jcv.2013.01.009_bib0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2007.10.020","article-title":"Mutations of neuraminidase implicated in neuraminidase inhibitors resistance","volume":"41","author":"Ferraris","year":"2008","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2013.01.009_bib0040","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/QCO.0b013e3283199797","article-title":"The potential impact of neuraminidase inhibitor resistant influenza","volume":"21","author":"Lackenby","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.jcv.2013.01.009_bib0045","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/375799","article-title":"High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza","volume":"188","author":"Shiraishi","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.jcv.2013.01.009_bib0050","first-page":"ii11","article-title":"Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients","volume":"65","author":"Dutkowski","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jcv.2013.01.009_bib0055","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1097\/INF.0b013e31824671ab","article-title":"Antiviral treatment of influenza in children","volume":"31","author":"Garg","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jcv.2013.01.009_bib0060","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/AOG.0b013e318229e484","article-title":"Influenza-like illness in hospitalized pregnant and postpartum women during the 2009\u20132010 H1N1 pandemic","volume":"118","author":"Varner","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jcv.2013.01.009_bib0065","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMc1111078","article-title":"Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza","volume":"365","author":"Hurt","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2013.01.009_bib0070","doi-asserted-by":"crossref","DOI":"10.2807\/ese.13.05.08026-en","article-title":"Emergence of resistance to oseltamivir among influenza A(H1N1) viruses in Europe","volume":"13","author":"Lackenby","year":"2008","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jcv.2013.01.009_bib0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1502.081031","article-title":"Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007\u201308","volume":"15","author":"Hauge","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jcv.2013.01.009_bib0080","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid1504.181280","article-title":"Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007\u201308 season","volume":"15","author":"Meijer","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jcv.2013.01.009_bib0085","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Oseltamivir-Resistance Working Group, Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jcv.2013.01.009_bib0090","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1750-2659.2009.00072.x","article-title":"Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers","volume":"3","author":"Garc\u00eda","year":"2009","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jcv.2013.01.009_bib0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.antiviral.2009.03.003","article-title":"Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa","volume":"83","author":"Hurt","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcv.2013.01.009_bib0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-11-134","article-title":"Systematic review of influenza resistance to the neuraminidase inhibitors","volume":"11","author":"Thorlund","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jcv.2013.01.009_bib0105","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.05.19784-en","article-title":"Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010\/11","volume":"16","author":"Lackenby","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jcv.2013.01.009_bib0110","doi-asserted-by":"crossref","DOI":"10.2807\/ese.17.36.20266-en","article-title":"Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012","volume":"17","author":"Meijer","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jcv.2013.01.009_bib0115","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.04.19776-en","article-title":"Pandemic influenza A(H1N1) 2009 molecular characterisation and duration of viral shedding in intensive care patients in Bordeaux, south-west France, May 2009 to January 2010","volume":"16","author":"Malato","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jcv.2013.01.009_bib0120","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1056\/NEJMc0910060","article-title":"Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis","volume":"361","author":"Baz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcv.2013.01.009_bib0125","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.46.19412-en","article-title":"Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses","volume":"14","author":"Ciancio","year":"2009","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jcv.2013.01.009_bib0130","unstructured":"European Centre for Disease Prevention and Control, Community Network of Reference Laboratories for Human Influenza (CNRL). CNRL Recommendation on strains for antiviral susceptibility testing: referral of influenza strains to WHO Collaborating Centre London; 2010. Available from the European Influenza Surveillance Network (EISN) Extranet Library (http:\/\/ecdc.europa.eu)."},{"key":"10.1016\/j.jcv.2013.01.009_bib0135","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/JCM.41.2.742-750.2003","article-title":"Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network","volume":"41","author":"Wetherall","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jcv.2013.01.009_bib0140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcv.2012.11.005","article-title":"Evaluation of influenza virus antiviral susceptibility testing in Europe: results from the first external quality assessment exercise","volume":"56","author":"Thompson","year":"2013","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2013.01.009_bib0145","first-page":"215","article-title":"Visual presentation of data by means of box plots","volume":"18","author":"Massart","year":"2005","journal-title":"LC\u2013GC Eur"},{"key":"10.1016\/j.jcv.2013.01.009_bib0150","unstructured":"Royal Society of Chemistry. Robust statistics: a method of coping with outliers. Analytical Methods Committee Technical Brief 6; 2001. Available from: http:\/\/www.rsc.org\/images\/robust-statistics-technical-brief-6_tcm18-214850.pdf."},{"key":"10.1016\/j.jcv.2013.01.009_bib0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcv.2009.09.030","article-title":"Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase","volume":"47","author":"van der Vries","year":"2010","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jcv.2013.01.009_bib0160","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jviromet.2008.07.017","article-title":"A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1","volume":"153","author":"Duwe","year":"2008","journal-title":"J Virol Methods"},{"key":"10.1016\/j.jcv.2013.01.009_bib0165","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2009.09.010","article-title":"Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification","volume":"84","author":"Steain","year":"2009","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jcv.2013.01.009_bib0170","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1128\/AAC.00316-11","article-title":"Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis","volume":"55","author":"Duan","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcv.2013.01.009_bib0175","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s10096-011-1482-9","article-title":"Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1) A(H1N1)2009, and A(H3N2) subtypes by melting point analysis","volume":"31","author":"Redlberger-Fritz","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jcv.2013.01.009_bib0180","doi-asserted-by":"crossref","first-page":"e37095","DOI":"10.1371\/journal.pone.0037095","article-title":"I223R mutation in influenza A(H1N1)pdm09 neuraminidase confers reduced susceptibility to oseltamivir and zanamivir and enhanced resistance with H275Y","volume":"7","author":"Legoff","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2013.01.009_bib0185","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/508777","article-title":"Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child","volume":"43","author":"Baz","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcv.2013.01.009_bib0190","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.antiviral.2009.11.005","article-title":"Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses","volume":"85","author":"Okomo-Adhiambo","year":"2010","journal-title":"Antiviral Res"}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653213000334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653213000334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T02:14:08Z","timestamp":1644200048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653213000334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1386653213000334"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2013.01.009","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}